Last updated: April 26, 2026
What is “VUSION” in the supply-chain context?
“VUSION” is marketed as a pharmaceutical drug product name, but the term can map to different products by country, dosage form, and marketing authorization holder. A supplier map depends on the exact labeled product (strength, dosage form, and MAH/labeler). Without that product-level identification, supplier assignments to the drug product, its active pharmaceutical ingredient (API), and its key excipients cannot be produced accurately.
Who supplies VUSION’s API?
No complete, product-specific, verifiable supplier dataset is available in the provided information set. API manufacturers are tied to the specific VUSION product dossier (MAA/NDA), jurisdictional filings, and current commercial supply agreements. Without the exact VUSION identification, any list of API suppliers would be speculative.
Who supplies VUSION’s drug product manufacturing (fill-finish and packaging)?
Fill-finish and packaging suppliers depend on the dosage form and site nominations in the regulatory dossier (for example, sterile vs non-sterile, depot vs oral solid, sachet vs blister). No verified, product-specific manufacturing network is provided.
Who supplies key excipients and packaging materials for VUSION?
Excipients (binder, disintegrant, lubricant, coating system, stabilizers) and packaging (blister aluminum foil, PVC/PVDC, child-resistant closures, cartridges) are specified by formulation and commercial scale-up decisions. No formulation-level bill of materials or packaging specifications are provided, so key excipient and packaging suppliers cannot be listed without risking errors.
What supplier data is typically used to build the VUSION supplier map?
A defensible supplier list is built from at least one of the following sources, linked to the exact product:
- Marketing authorization and variations (MAA/CTA dossier content, where supplier sites and control strategy are captured)
- Batch release and inspection outcomes where site names appear
- Product labeler/MAH disclosures and public manufacturer lists on regulatory portals
- Excipient and packaging vendor lists in validated quality systems (access-restricted)
No such inputs are included.
Supplier table (not populated)
| Supply chain layer |
Verified VUSION suppliers |
Evidence basis |
Status |
| API manufacturer(s) |
Not available |
Product-specific dossier/label data required |
Not provided |
| Drug product manufacturer (DS/DP) |
Not available |
Product-specific site nomination required |
Not provided |
| Fill-finish/sterile compounding (if applicable) |
Not available |
Dosage form required |
Not provided |
| Excipients (QC-relevant grades) |
Not available |
Formulation required |
Not provided |
| Packaging (primary and secondary) |
Not available |
Packaging configuration required |
Not provided |
Key Takeaways
- A supplier list for “VUSION” must be tied to the exact marketed product (strength, dosage form, and labeler/MAH) to avoid misattribution across markets.
- With the information provided, no verified suppliers can be listed for the API, drug product manufacturing, excipients, or packaging.
- Any attempt to name suppliers would be speculative and not fit for R&D or investment decision-making.
FAQs
1. Can you list VUSION API suppliers without knowing the exact VUSION product (strength/dosage form/labeler)?
No; API suppliers differ by product variant and market approvals.
2. Do drug product suppliers always match API suppliers?
No. The drug product manufacturer or fill-finish site is often different from the API site.
3. Are excipient and packaging suppliers fixed once approved?
Not always. Changes happen via variations, tech transfers, and approved alternate sources.
4. What sources normally confirm supplier identity for a drug product?
Regulatory dossier content, public regulatory listings tied to the exact product, and batch release/inspection records that name sites.
5. Can “VUSION” refer to multiple products in different jurisdictions?
Yes. The same brand or name can map to different formulations and authorizations across countries.
References
(No sources were cited because no product-specific supplier evidence was provided in the prompt.)
